Our results substantiate the contributory role of Gal-3 in the fibrotic pathogenesis associated with endometriosis, indicating that Gal-3 has the potential to be a promising therapeutic target for treating fibrosis in endometriosis. The gene discussed is LGALS3; the disease is endometriosis.